Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer. - Kirk PS; Zhu K; Zheng Y; Newcomb LF; Schenk JM; Brooks JD; Carroll PR; Dash A; Ellis WJ; Filson CP; Gleave ME; Liss M; et al. (Cancer, 2022)